Eligibility

People with serious heart conditions leading to heart failure may be most appropriately treated with a heart transplant if other treatment options have been considered or tried. Heart failure may be caused by many medical conditions, including:

Your transplant team will evaluate you to determine whether a heart transplant may be safe and beneficial for you. Your comprehensive evaluation includes blood tests, imaging studies and other tests. Doctors will check you for other serious conditions, including chronic infections and cancer.

Most people who are evaluated are determined to be eligible for a heart transplant. Your doctors and transplant team will work with you to promote wellness, lower your risks and improve your outcome after heart transplant. A care team member will talk with you about the importance of taking your immunosuppressant (anti-rejection) medications to keep your body from rejecting your heart.

Aug. 23, 2016
References
  1. Scientific Registry of Transplant Recipients. http://www.srtr.org/default.aspx. Accessed May 13, 2016.
  2. U.S. News & World Report. U.S. News Best Hospitals 2015-16. http://health.usnews.com/best-hospitals/rankings. Accessed Feb. 22, 2016.
  3. Cook AJ. Allscripts EPSi. Mayo Clinic, Rochester, Minn. May 2, 2014.
  4. Heart transplant program to resume in fall of 1986. Mayovox. 1986:37;1.
  5. Mancini D. Indications and contraindications for cardiac transplantation. http://www.uptodate.com/home. Accessed April 22, 2016.
  6. Barbara Woodward Lips Patient Education Center. Heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  7. Yip DS (expert opinion). Mayo Clinic, Jacksonville, Fla. June 20, 2016.
  8. Barbara Woodward Lips Patient Education Center. Your child's heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  9. Johnson JN (expert opinion). Mayo Clinic, Rochester, Minn. June 20, 2016.
  10. Vucicevic D, et al. Sirolimus based immunosuppression results in lower incidence of post-transplantation lymphoproliferative disorders in heart transplant recipients. Journal of Heart and Lung Transplantation. 2015;34:s86.
  11. Kalya A, et al. Role of total artificial heart in the management of heart transplant rejection and retransplantation: Case report and review. Clinical Transplantation. 2013;27:e348.
  12. Shankar N, et al. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation. 2013;96:324.
  13. Barbara DW, et al. The perioperative management of patients undergoing combined heart-liver transplantation. Transplantation. 2015;99:139.
  14. Burkhart HM, et al. Regenerative therapy for hypoplastic left heart syndrome: First report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells. Journal of Thoracic and Cardiovascular Surgery. 2015;149:e35. http://www.sciencedirect.com/science/article/pii/S002252231401602X. Accessed May 5, 2016.
  15. Pundi KN, et al. 40-year follow-up after the Fontan operation: Long-term outcomes of 1,052 patients. Journal of the American College of Cardiology. 2015;66:1700.
  16. Rosenbaum AN, et al. Current indications, strategies and outcomes with cardiac transplantation for cardiac amyloidosis and sarcoidosis. Current Opinion in Organ Transplantation. 2015;20:584.
  17. Grupper A, et al. Increased risk of antibody mediated rejection and subsequent allograft vasculopathy in women post cardiac transplantation. Journal of Women's Health. 2015;24:A-16.
  18. Rosenbaum AN, et al. Association between early cardiac rehabilitation and long-term survival in cardiac transplant recipients. Mayo Clinic Proceedings. 2016;91:149.
  19. Medical practice report: Heart transplant. Press Ganey. http://www.pressganey.com/. Accessed May 24, 2016.
  20. Khandhar SJ, et al. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation. Journal of Heart and Lung Transplantation. 2013;32:596.
  21. Mayo Clinic Children's Center becomes first accredited pediatric heart failure institute in Minnesota and fourth in the nation (news release). http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=458981. Accessed June 27, 2016.
  22. Doctors name America's top residency programs (news release). U.S. News & World Report. http://health.usnews.com/health-news/top-doctors/articles/2014/02/20/doctors-name-americas-top-residency-programs. Accessed June 27, 2016.
  23. Centers of excellence. Extracorporeal Life Support Organization. https://www.elso.org/Excellence/CentersofExcellence.aspx. Accessed June 27, 2016.
  24. Heilman RL (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. June 24, 2016.